Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 0.12% | 283.74 | 1.5% | $847.25m | |
| GILD | Gilead Sciences, Inc. | 0.98% | 86.26 | 1.0% | $795.01m | |
| MRNA | Moderna, Inc. | -0.23% | 176.40 | 0.0% | $769.19m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.01% | 312.98 | 1.9% | $482.01m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.12% | 736.23 | 2.6% | $473.28m | |
| BIIB | Biogen, Inc. | 0.56% | 305.15 | 1.8% | $355.07m | |
| ILMN | Illumina, Inc. | -1.39% | 218.99 | 3.2% | $270.73m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 5.70% | 2.78 | 0.7% | $194.33m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.89% | 96.92 | 4.2% | $161.47m | |
| BNTX | BioNTech SE | -0.88% | 154.85 | 0.0% | $152.12m | |
| MRTX | Mirati Therapeutics, Inc. | 2.89% | 98.62 | 1.6% | $132.21m | |
| TECH | Bio-Techne Corp. | 0.79% | 338.97 | 4.5% | $123.89m | |
| AXSM | Axsome Therapeutics, Inc. | 1.07% | 56.82 | 1.6% | $80.71m | |
| NVAX | Novavax, Inc. | -2.88% | 16.54 | 75.3% | $70.44m | |
| HALO | Halozyme Therapeutics, Inc. | 0.59% | 54.67 | 18.4% | $64.50m |
Company Profile
Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.